52 results
Keyword clopidogrel Remove keyword
Responsible body
PRAC Remove PRAC filter
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 July 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 03/07/2023 to 06/07/2023, Last updated: 21/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28-31 August 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 28/08/2023 to 31/08/2023, Last updated: 28/08/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 April 2023
European Medicines Agency, Amsterdam, the Netherlands, from 11/04/2023 to 14/04/2023, Last updated: 07/07/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 31/03/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 31/03/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 March 2018
European Medicines Agency, London, UK, from 05/03/2018 to 08/03/2018, Last updated: 05/03/201814 4.1.2. Clopidogrel – CLOPIDOGREL APOTEX (CAP CLOPIDOGREL BGR (CAP CLOPIDOGREL HCS (CAP … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 August - 2 September 2016
European Medicines Agency, London, UK, from 30/08/2016 to 02/09/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 23-26 November 2020
Virtual meeting, from 23/11/2020 to 26/11/2020, Last updated: 27/11/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 March 2014
European Medicines Agency, London, UK, from 03/03/2014 to 06/03/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 July 2017
European Medicines Agency, London, UK, from 03/07/2017 to 06/07/2017, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 January 2014
European Medicines Agency, London, UK, from 06/01/2014 to 09/01/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 July 2014
European Medicines Agency, London, UK, from 07/07/2014 to 10/07/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 March 2013
European Medicines Agency, London, UK, from 04/03/2013 to 07/03/2013, Last updated: 02/06/2012 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-3 October 2012
PRAC, Last updated: 05/10/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-5 September 2012
European Medicines Agency, London, UK, from 03/09/2012 to 05/09/2012, Last updated: 02/06/2012EMA/PRAC/432046/2012 Page 4/10 4.1.3. Clopidogrel – PLAVIX (CAP) & generic … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 January 2015
European Medicines Agency, London, UK, from 06/01/2015 to 09/01/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2015
European Medicines Agency, London, UK, from 07/04/2015 to 10/04/2015, Last updated: 20/05/201516 4.2.1. Clopidogrel – ISCOVER (CAP), PLAVIX … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 May 2014
PRAC, Last updated: 08/05/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2014
European Medicines Agency, London, UK, from 07/04/2014 to 10/04/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2016
European Medicines Agency, London, UK, from 08/02/2016 to 11/02/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 June 2014
European Medicines Agency, London, UK, from 10/06/2014 to 13/06/2014, Last updated: 13/08/2013